|
TARDBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.17910000944022E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
9.88098491916389E-15 |
| Stage1-vs-Stage2 |
6.115800E-01 |
| Stage1-vs-Stage3 |
6.404100E-02 |
| Stage1-vs-Stage4 |
5.375600E-02 |
| Stage2-vs-Stage3 |
9.499500E-02 |
| Stage2-vs-Stage4 |
5.873500E-02 |
| Stage3-vs-Stage4 |
6.356200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.95450000004283E-06 |
| Normal-vs-Asian |
1.13470344231814E-11 |
| Caucasian-vs-AfricanAmerican |
1.986220E-01 |
| Caucasian-vs-Asian |
7.162600E-01 |
| AfricanAmerican-vs-Asian |
3.382600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.032400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13495887635418E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
6.421500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.910200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.684200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.795200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.538600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.667800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.806200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.19249999999782E-05 |
| Classical-VS-Follicular |
3.450800E-01 |
| Classical-VS-Other |
2.404800E-01 |
| Classical-VS-Normal |
2.43990383452797E-11 |
| Tall-VS-Follicular |
7.358800E-03 |
| Tall-VS-Other |
4.915200E-01 |
| Tall-VS-Normal |
1.62525548574877E-12 |
| Follicular-VS-Other |
5.395600E-01 |
| Follicular-VS-Normal |
8.93385365685617E-12 |
| Other-VS-Normal |
2.228900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
8.67528271442097E-13 |
| N0-vs-N1 |
2.527000E-01 |
|
|
